In connection with the implementation of the project titled ”Design and development of nanoparticle RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids”, by BS Biotechna SA, under contract No. 2022/ABM/06/00005-00 for co-financing of a commercial project as part of the Competition for the development of targeted or personalized medicine based on medicinal products based on nucleic acids and small-molecule compounds. The Ordering Party conducts market research regarding purchase costs DSPE Carbamate PEG Amine, HCl Salt, MW 2000 (GMP grade).
In order to submit an offer, please read the detailed content of the advertisement included in the market research 78/2024 and send the completed offer form.